Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied UV commercializes patented UVC-based surface and air disinfection technologies targeting healthcare-acquired infections and airborne pathogens. Its products are FDA-cleared Class II medical devices with proven efficacy in clinical settings. The company has expanded its portfolio through acquisitions but filed for Chapter 11 bankruptcy protection in May 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied UV.